Immunologic studies in presumed amniotic fluid embolism

Objective: To evaluate the potential role of immunologic mechanisms that in volve mast cell degranulation (anaphylaxis) or complement activation in the mechanism of amniotic fluid embolism. Methods: This study was a case series of nine women with presumed amniotic fluid embolism and a control group of 22 women who had normal labor. Women were from community and tertiary referral hospitals in Japan and the United States. Main outcome measures were maternal peripartum complement levels ( C3 and C4), serum levels of tryptase, urinary histamine concentrations, and serum levels of a fetal antigen (sialyl Tn). Results: Serum tryptase and urinary histamine measurements were negative in women with amniotic fluid embolism; seven of nine had elevated levels of f etal antigen. All eight who had serum available for testing had abnormally low levels of complement. Mean C3 level of 44.0 mg/dL and C4 level of 10.7 mg/dL were significantly lower than corresponding postpartum control values of 117.3 mg/dL and 29.4 mg/dL (P = .018 for C3, P = .012 for C4). Postpart um C3 and C4 levels decreased by 8% and 5%, respectively, compared with int rapartum values (P = .003 for C3, P = .021 for C4) but were still within no rmal range. Conclusion: Serologic findings suggest a role for complement activation in the mechanism of amniotic fluid embolism. Laboratory data from this series did not implicate mast cell degranulation (anaphylaxis) in the pathophysiol ogy of the disease. (C) 2001 by The American College of Obstetricians and G ynecologists.